SuperworthPacific Biosciences of California market cap PACB
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $655.9M
- Highest close in our data
- $9.1B
- Feb 2021
Pacific Biosciences of California is worth $655.9M at the close on Oct 23, 2026, at $2.11 a share.
That is up 8% over the last year and down 88% over five years.
Its highest close in our data was $9.1B in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $655.9M | $347.9M | $789.5M | +23% |
| 2025 | $534.4M | $276.6M | $721.6M | +5% |
| 2024 | $509.4M | $356.8M | $2.5B | −81% |
| 2023 | $2.6B | $1.7B | $3.4B | +42% |
| 2022 | $1.8B | $951.4M | $3.7B | −59% |
| 2021 | $4.5B | $4.5B | $9.1B | −3% |
| 2020 | $4.7B | $405.8M | $4.9B | +483% |
| 2019 | $801.9M | $714.7M | $1.1B | −27% |
| 2018 | $1.1B | $267.9M | $1.2B | +256% |
| 2017 | $306.9M | $297.5M | $623M | −13% |
| 2016 | $352.1M | $352.1M | $990M | −65% |
| 2015 | $1B | $299.9M | $1B | +81% |
| 2014 | $558.7M | $298.2M | $558.7M | +64% |
| 2013 | $341.3M | $106.7M | $364.7M | +264% |
| 2012 | $93.8M | $66.3M | $264.7M | −39% |
| 2011 | $153.5M | $134.3M | $324.1M | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Pacific Biosciences of California's size, closest first, today.
| Company | Market cap |
|---|---|
| PACBPacific Biosciences of California | $655.9M |
| NRCNRC Health | $485.1M |
| CDNACareDx | $3.6B |
| VCYTVeracyte | $3.9B |
| ICCCImmucell | $93.1M |
| BLLNBillionToOne | $5.1B |
| LNTHLantheus | $6.5B |
| Peer median | $3.7B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Pacific Biosciences of California
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.